drugset / Trial / NCT05921292
Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies
NaSingle-groupOpen-labelOther
Summary
The goal of this clinical trial is to evaluate the use of Omeza combination therapy with Standard of Care. The main question it aims to answer is: \- Can Omeza combination therapy with Standard of Care enable chronic wounds to begin a healing trajectory in a 4-week period? Patients will be treated with: * OCM™ Wound Matrix * Omeza combination therapy * Standard of Care
Timeline
- Start
- 2022-07-11
- Primary completion
- 2024-01-22
- Completion
- 2024-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 2 ml | Topical |
| Subject | Omeza skin protectant | Unknown | 2 ml | Topical |
| Subject | Omeza® Complete Matrix | Unknown | 1.6 g | Topical |